MINI FUTURE LONG - CELSIUS HLDGS Share Price

Certificat

DE000ME3X2F6

Market Closed - Börse Stuttgart 12:56:28 29/06/2024 am IST
2.13 EUR +2.90% Intraday chart for MINI FUTURE LONG - CELSIUS HLDGS
Current month-49.41%
1 month-62.63%
Date Price Change
28/24/28 2.13 +2.90%
27/24/27 2.07 +0.98%
26/24/26 2.05 -1.44%
25/24/25 2.08 -15.10%
24/24/24 2.45 -6.49%

Delayed Quote Börse Stuttgart

Last update June 29, 2024 at 12:56 am IST

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME3X2F
ISINDE000ME3X2F6
Date issued 20/11/2023
Strike 33.99 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.71
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 5.84
Lowest since issue 1.52

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.09 USD
Average target price
83.43 USD
Spread / Average Target
+46.14%
Consensus